Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation

被引:1
|
作者
Niwa, Toshiro [1 ]
Sasaki, Shoko [1 ]
Yamamoto, Yuka [1 ]
Tanaka, Mayu [1 ]
机构
[1] Shujitsu Univ, Sch Pharm, Naka Ku, 1-6-1 Nishigawara, Okayama 7038516, Japan
关键词
DOPAMINE FORMATION; GENETIC-POLYMORPHISM; STEROID-HORMONES; P-TYRAMINE; OXIDATION; SUBSTRATE; ALLOPREGNANOLONE; NEUROSTEROIDS; METABOLISM; ENZYMES;
D O I
10.1007/s13318-022-00784-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Objectives Herein, hydroxylation activities at the 6 beta-position and 21-position of progesterone mediated by human cytochrome P450 (CYP) 2D6 and its variants and the effects of psychotropic drugs on these hydroxylation activities were compared to clarify whether CYP2D6 polymorphisms and psychotropic drugs impact neurosteroid levels in the brain. Methods Progesterone was incubated with CYP2D6.1, CYP2D6.2 (Arg296Cys, Ser486Thr), CYP2D6.10 (Pro34Ser, Ser486Thr), and CYP2D6.39 (Ser486Thr) in the absence or presence of typical psychotropic drugs (fluvoxamine, fluoxetine, paroxetine, fluphenazine, and milnacipran) and endogenous steroids (testosterone and cortisol). Then, 6 beta- and 21-hydroxyprogesterone levels were determined by high-performance liquid chromatography. Results Although the Michaelis-Menten constants (K-m) for progesterone 6 beta- and 21-hydroxylation reactions mediated by the different CYP2D6 variants were similar, the maximal velocity (V-max) values of the reactions mediated by CYP2D6.1 and CYP2D6.2 were the highest, followed by those mediated by CYP2D6.39 and CYP2D6.10. Thus, the of progesterone 6 beta- and/or 21-hydroxylation reactions mediated by CYP2D6.1 and CYP2D6.2 showed the highest V-max/K-m values, followed by the reactions mediated by CYP2D6.39. All investigated compounds inhibited progesterone 21-hydroxylation mediated by CYP2D6 variants at high concentrations. Interestingly, at low concentrations, fluoxetine increased progesterone 21-hydroxylation mediated by CYP2D6.1, but not that mediated by CYP2D6.2 or CYP2D6.10. In addition, the K-m value for CYP2D6.2 was elevated in the presence of fluoxetine, whereas the value for CYP2D6.1 was unaltered; however, V-max values of both CYP2D6.1 and CYP2D6.2 were increased. Paroxetine competitively inhibited CYP2D6.1- and CYP2D6.2-mediated progesterone 21-hydroxylation. Conclusions These results suggest that CYP2D6 polymorphism can affect the stimulation/inhibition of progesterone 21-hydroxylation.
引用
收藏
页码:741 / 747
页数:7
相关论文
共 50 条
  • [1] Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation
    Toshiro Niwa
    Shoko Sasaki
    Yuka Yamamoto
    Mayu Tanaka
    European Journal of Drug Metabolism and Pharmacokinetics, 2022, 47 : 741 - 747
  • [2] Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro
    Wang, Zhe
    Wang, Li
    Xu, Ren-ai
    Zhan, Yun-yun
    Huang, Cheng-ke
    Dai, Da-peng
    Cai, Jian-ping
    Hu, Guo-xin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1909 - 1916
  • [3] Cytochrome P450 2D6 polymorphism and character traits
    Suzuki, E
    Kitao, Y
    Ono, Y
    Iijima, Y
    Inada, T
    PSYCHIATRIC GENETICS, 2003, 13 (02) : 111 - 113
  • [4] Cytochrome P450 2D6
    Owen, Ryan P.
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (07): : 559 - 562
  • [5] Polymorphism of Human Cytochrome P450 2D6 and Its Clinical SignificancePart II
    Shu-Feng Zhou
    Clinical Pharmacokinetics, 2009, 48 : 761 - 804
  • [6] Polymorphism of Human Cytochrome P450 2D6 and Its Clinical SignificancePart I
    Shu-Feng Zhou
    Clinical Pharmacokinetics, 2009, 48 : 689 - 723
  • [7] PERSONALIZED PHARMACOTHERAPY IN A PATIENT WITH CYTOCHROME P450 2D6 POLYMORPHISM
    Paul, Sheeba
    Lu, Celia
    Block, Lauren
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S561 - S562
  • [8] Crystal structure of human cytochrome P450 2D6
    Rowland, P
    Blaney, FE
    Smyth, MG
    Jones, JJ
    Leydon, VR
    Oxbrow, AK
    Lewis, CJ
    Tennant, MG
    Modi, S
    Eggleston, DS
    Chenery, RJ
    Bridges, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) : 7614 - 7622
  • [9] Allosteric effects of cytochrome P450 reductase on cytochrome P450 2D6
    Roberts, GCK
    Modi, S
    Gilham, DE
    Sutcliffe, MJ
    Lian, LY
    Primrose, WU
    Wolf, CR
    FASEB JOURNAL, 1997, 11 (09): : A789 - A789
  • [10] Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part II
    Zhou, Shu-Feng
    CLINICAL PHARMACOKINETICS, 2009, 48 (12) : 761 - 804